Rapid evaluation of PBMC counting and viability

19 Jan 2021

Peripheral Blood Mononuclear Cells (PBMCs) are a vital source material used in myriad research applications, including single-cell sequencing to vaccine development and toxicological studies. In this application note, Logos Biosystems demonstrates the ability of the new dual fluorescent LUNA-FX7™ Automated Cell Counter in counting leukocytes in whole blood and the PBMCs isolated from whole blood samples.

LUNA-FX7™ Automated Cell Counter

Logos Biosystems

The LUNA-FX7™ is our most powerful cell counter to date, with unmatched cell counting accuracy, new 1, 3 and 8-chamber slide options, state of the art optics, dual fluorescent and brightfield detection, and precision autofocus. The LUNA-FX7™’s new features such as the Bioprocess mode, Quality Control mode, and the CountWire™ (21 CFR Part 11 compliant) software will help companies and facilities meet and surpass quality and regulatory requirements.

(64)

Links

Tags

Rapid evaluation of PBMC counting and viability